From November 12 to 14,2025, the 93rd China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (API China) was successfully held at Chongqing International Expo Center. As a long-term participant in this event, our company, as a pharmaceutical API enterprise, once again deeply engaged in this industry grand event covering the entire pharmaceutical industry chain. 

This year's exhibition, centered on the mission of "Innovation and Synergy for Pharmaceutical Industry Advancement", brought together over 1,000 enterprises across all sectors and nearly 30,000 industry professionals. Spanning 120,000 square meters, the event created a comprehensive platform integrating product showcases, technical exchanges, and business collaborations. Specialized zones like the Biopharmaceutical Supply Chain and Pharmaceutical R&D Supply Chain were established to precisely address the entire "Target Discovery to Commercial Production" lifecycle. Concurrently, over 30 high-level forums focused on policy analysis and technological innovation, making the exhibition a key window for understanding industry trends.

 To precisely align with industry demands, our company formed a multi-disciplinary exhibition team comprising sales and marketing departments under the leadership of the General Manager. We established a specially designed booth in the core exhibition area for active pharmaceutical ingredients (APIs), effectively communicating our brand philosophy through the platform. The exhibition also provided exclusive resources such as interpretations of centralized procurement policies and international registration practices, supporting our future business strategies. The release of the "API-Formulation Integrated Business Analysis Report" and practical case studies from multiple enterprises demonstrate that the synergistic development of "APIs + formulations" has become a key strategy for addressing centralized procurement and expanding international markets, while the survival space for single API suppliers is shrinking. Facing these severe industry challenges, our company is actively exploring future development directions and planning its objectives for the next five years. 

The API China exhibition has served as a vital platform for our company to connect with markets, identify trends, and consolidate resources. Going forward, we will leverage this experience to address development gaps, seize industry opportunities, and drive high-quality growth through green transformation, integrated operations, and global expansion.